MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/pubmed/fdaf134

Медицинская библиотека · Journal of public health (Oxford, England) · 2026

A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial.

Wu En-Ling, Meyer Makenna, Almirol Ellen, Zhao Xiaoquan, Payne Gjvar, Bhavan Kavita, Zaller Nickolas, Montgomery Jerome, Hotton Anna, Brewer Russell, Johns Michelle M, Aalsma Matthew C, Knopf Amelia S, Hodge Sarah, Johnson O'Dell, Carter Chandler C, Bucala Matthew, Hazra Aniruddha, Shah Monal, Pho Mai T, Bouris Alida, Walters Suzan M, Umutoni Victoria, Pyra Maria, Birkett Michelle, Phillips Gregory, Zapolski Tamika C B, Webb Jeannette, Smartt Jillian, Horton Heather, Durrell Mainza, Fletcher Scott, Schneider John A

СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Community Network-Driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central United States (C3) evaluates the use of Social Network Strategy (SNS) with educational messaging to improve COVID-19 testing and vaccination among people most impacted by the pandemic.

METHODS

We enrolled individuals with low-income who identify as Hispanic/Latino or a history of criminal legal involvement (CLI) through social network referral and randomized participants 1:1 to SNS vs. SNS plus messaging (SNS+), which included a self-affirmation activity and educational video. We assessed for COVID-19 testing and, among baseline unvaccinated participants, vaccination at 21 days, and used mixed effects logistic regression to examine outcomes.

RESULTS

Of 1328 participants (SNS+: 667, SNS: 661), 46.6% identified as Black/African American, 33.4% as Hispanic/Latino, and 43.8% reported history of CLI. Majority (66.3%) reported testing and, of unvaccinated participants, 11.9% reported vaccination at follow-up. There were no differences in testing (aOR 0.89, 95% CI 0.71, 1.11, P = .49) or vaccination (aOR 1.46, 95% CI 0.78, 2.76, P = .30) among participants who received SNS+ compared to SNS after adjusting for recruitment wave and clustering within sites and referral chains.

CONCLUSIONS

Social network referral successfully engaged communities disproportionately impacted by COVID-19 in testing and vaccination. Compared to SNS alone, adding educational messaging did not increase testing or vaccination. Additional work is needed to implement SNS to increase vaccination rates among vulnerable populations.

Для цитирования: Wu En-Ling, Meyer Makenna, Almirol Ellen, Zhao Xiaoquan, Payne Gjvar, Bhavan Kavita, Zaller Nickolas, Montgomery Jerome, Hotton Anna, Brewer Russell, Johns Michelle M, Aalsma Matthew C, Knopf Amelia S, Hodge Sarah, Johnson O'Dell, Carter Chandler C, Bucala Matthew, Hazra Aniruddha, Shah Monal, Pho Mai T, Bouris Alida, Walters Suzan M, Umutoni Victoria, Pyra Maria, Birkett Michelle, Phillips Gregory, Zapolski Tamika C B, Webb Jeannette, Smartt Jillian, Horton Heather, Durrell Mainza, Fletcher Scott, Schneider John A. A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial.. Journal of public health (Oxford, England). 2026. DOI: 10.1093/pubmed/fdaf134.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.